Page 45 - Read Online
P. 45

2009;30:759-68.                                     Induction of TNF-alpha by LPS in Schwann cell is regulated by
          48.   Ros-Bernal F, Hunot S, Herrero MT, Microglial glucocorticoid receptors   MAPK activation signals. Cell Mol Neurobiol 2007;27:909-21.
             play a pivotal role in regulating dopaminergic neurodegeneration in   70.   Brun P, Gobbo S, Caputi V, Spagnol L, Schirato G, Pasqualin M,
             parkinsonism. Microglial glucocorticoid receptors play a pivotal role   Levorato E, Palù G, Giron MC, Castagliuolo I. Toll like receptor-2
             in regulating dopaminergic neurodegeneration in parkinsonism. Proc   regulates production of glial-derived neurotrophic factors in murine
             Natl Acad Sci U S A 2011;108:6632-7.                intestinal smooth muscle cells. Mol Cell Neurosci 2015;68:24-35.
          49.   Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S,   71.   van Bergenhenegouwen J, Plantinga TS, Joosten LA, Netea MG,
             Masliah E, Hwang D, Lee HJ, Lee SJ. Neuron-released oligomeric   Folkerts G, Kraneveld AD, Garssen J, Vos AP. TLR2 & Co: a
             alpha-synuclein is an endogenous agonist of TLR2 for paracrine   critical analysis of the complex interactions between TLR2 and
             activation of microglia. Nat Commun 2013;4:1562.    coreceptors. J Leukoc Biol 2013;94:885-902.
          50.   Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning   72.   Oosting M, Cheng S-C, Bolscher JM, Vestering-Stenger R, Plantinga
             GK. Microglial activation mediates neurodegeneration related to   TS, Verschueren IC, Arts P, Garritsen A, van Eenennaam H, Sturm
             oligodendroglial alpha-synucleinopathy: implications for multiple   P, Kullberg BJ, Hoischen A, Adema GJ, van der Meer JW, Netea
             system atrophy. Mov Disord 2007;22:2196-203.        MG, Joosten LA. Human TLR10 is an anti-inflammatory pattern-
          51.   Brudek T, Winge K, Agander TK, Pakkenberg B. Screening of   recognition receptor. Proc Natl Acad Sci U S A 2014;111:E4478-84.
             Toll-like receptors expression in multiple system atrophy brains.   73.   Doorn KJ, Moors T, Drukarch B, van de Berg WD, Lucassen PJ,
             Neurochem Res 2013;38:1252-9.                       van Dam AM. Microglial phenotypes and toll-like receptor 2 in
          52.   Panaro MA, Lofrumento DD, Saponaro C, De Nuccio F, Cianciulli A,   the substantia nigra and hippocampus of incidental Lewy body
             Mitolo V, Nicolardi G. Expression of TLR4 and CD14 in the central   disease cases and Parkinson’s disease patients. Acta Neuropathol
             nervous system (CNS) in a MPTP mouse model of Parkinson’s-like   Commun 2014;2:90-1.
             disease. Immunopharmacol Immtoxicol 2008;30:729-40.  74.   Drouin-Ouellet J, St-Amour I, Saint-Pierre M, Lamontagne-Proulx
          53.   Landreth GE, Reed-Geaghan EG. Toll-like receptors in Alzheimer’s   J, Kriz J, Barker RA, Cicchetti F. Toll-like receptor expression in
             disease. Curr Top Microbiol Immunol 2009;336:137-53.  the blood and brain of patients and a mouse model of Parkinson’s
          54.   Kunda  PE, Cavicchia JC, Acosta CG. Lipopolysaccharides and   Disease. Int J Neuropsychopharmacol 2014; pii: pyu103.
             trophic factors regulate the LPS receptor complex in nodose and   75.   Kalinderi K, Bostantjopoulou S, Katsarou Z, Fidani L. TLR9 -1237
             trigeminal neurons. Neuroscience 2014;280:60-72.    T/C and TLR2  -194  to -174  del polymorphisms  and the risk  of
          55.   Min H, Lee H, Lim H, Jang YH, Chung SJ, Lee CJ, Lee SJ. TLR4   Parkinson’s disease in the Greek population: a pilot study. Neurol
             enhances  histamine-mediated pruritus  by  potentiating  TRPV1   Sci 2013;34:679-82.
             activity. Mol Brain 2014;7:59.                   76.   Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki
          56.   Maslinska D, Laure-Kamionowska M, Maslinski S. Toll-like   M, Arinami T. An association study of asthma and total serum
             receptors in rat brains injured by hypoxic-ischaemia or exposed to   immunoglobin E levels for Toll-like receptor polymorphisms in a
             staphylococcal alpha-toxin. Folia Neuropathol 2004;42:125-32.  Japanese population. Clin Exp Allergy 2004;34:177-83.
          57.   Arciszewski MB, Sand E, Ekblad E. Vasoactive intestinal peptide   77.   Beraud D, Twomey M, Bloom B, Mittereder A, Ton V, Neitzke K,
             rescues cultured rat myenteric neurons from lipopolysaccharide   Chasovskikh S, Mhyre TR, Maguire-Zeiss KA. alpha-Synuclein
             induced cell death. Regul Pept 2008;146:218-223.    Alters Toll-Like Receptor Expression. Front Neurosci 2011;5:80.
          58.   Lathia JD, Okun E, Tang SC, Griffioen K, Cheng A, Mughal MR,   78.   Roodveldt C, Labrador-Garrido A, Gonzalez-Rey E, Lachaud CC,
             Laryea G, Selvaraj PK, ffrench-Constant C, Magnus T, Arumugam TV,   Guilliams T, Fernandez-Montesinos R, Benitez-Rondan A, Robledo
             Mattson MP. Toll-like receptor 3 is a negative regulator of embryonic   G, Hmadcha A, Delgado M, Dobson CM, Pozo D. Preconditioning
             neural progenitor cell proliferation. J Neurosci 2008;28:13978-84.  of Microglia by α-Synuclein Strongly Affects the Response Induced
          59.   Menager P, Roux P, Megret F, Bourgeois JP, Le Sourd AM,   by Toll-like Receptor (TLR) Stimulation. PLoS One 2013;8:e79160.
             Danckaert A, Lafage M, Préhaud C, Lafon M. Toll-like receptor   79.   Frank S, Copanaki E, Burbach GJ, Müller UC, Deller T.
             3 (TLR3) plays a major role in the formation of rabies virus Negri   Differential regulation of toll-like receptor mRNAs in amyloid
             Bodies. PLoS Pathog 2009;5:e1000315.                plaque-associated brain tissue of aged APP23 transgenic mice.
          60.   Pleasure SJ, Page C, Lee VM. Pure, postmitotic, polarized   Neurosci Lett 2009;453:41-4.
             human  neurons derived from NTera 2 cells provide a system   80.   Jana M, Palencia CA, Pahan K. Fibrillar amyloid-beta peptides
             for expressing exogenous proteins in terminally differentiated   activate microglia via TLR2: implications for Alzheimer’s disease.
             neurons. J Neurosci 1992;12:1802-15.                J Immunol 2008;181:7254-62.
          61.   Schwartz  CM,  Spivak  CE,  Baker  SC,  McDaniel  TK,  Loring  JF,   81.   Richard KL, Filali M, Prefontaine P, Rivest S. Toll-like receptor
             Nguyen C, Chrest FJ, Wersto R, Arenas E, Zeng X, Freed WJ, Rao   2  acts  as a natural innate immune receptor to clear amyloid
             MS. NTera2: a model system to study dopaminergic differentiation   beta 1-42 and delay the cognitive decline in a mouse model of
             of human embryonic stem cells. Stem Cells Dev 2005;14:517-34.  Alzheimer’s disease. J Neurosci 2008;28:5784-93.
          62.   Lee H, Lee S, Cho IH, Lee SJ. Toll-like receptors: sensor molecules   82.   Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE. CD14
             for detecting damage to the nervous system. Curr Protein Pept Sci   and toll-like receptors 2 and 4 are required for fibrillar A{beta}-
             2013;14:33-42.                                      stimulated microglial activation. J Neurosci 2009;29:11982-92.
          63.   Carpentier PA, Duncan DS, Miller SD. Glial toll-like receptor   83.   Schutze S, Loleit T, Zeretzke M, Bunkowski S, Brück W, Ribes S, Nau
             signaling in central nervous system infection and autoimmunity.   R. Additive Microglia-Mediated Neuronal Injury Caused by Amyloid-
             Brain Behav Immun 2008;22:140-47.                   beta and Bacterial TLR Agonists in Murine Neuron-Microglia Co-
          64.   Aravalli RN, Peterson PK, Lokensgard JR. Toll-like receptors in   Cultures Quantified by an Automated Image Analysis using Cognition
             defense and damage of the central nervous system. J Neuroimmune   Network Technology. J Alzheimers Dis 2012;31:651-57.
             Pharmacol 2007;2:297-312.                        84.   Lotz M, Ebert S, Esselmann H, Iliev AI, Prinz M, Wiazewicz N,
          65.   Lehnardt S. Innate immunity and neuroinflammation in the CNS:   Wiltfang J, Gerber J, Nau R. Amyloid beta peptide 1-40 enhances
             the role of microglia in Toll-like receptor-mediated neuronal injury.   the action of Toll-like receptor-2 and -4 agonists but antagonizes
             Glia 2010;58:253-263.                               Toll-like receptor-9-induced inflammation in primary mouse
          66.   Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, Lee SJ. Necrotic   microglial cell cultures. J Neurochem 2005;94:289-98.
             neuronal cells induce inflammatory Schwann cell activation via   85.   Li H-Y, Hu J, Zhao S, Yuan ZY, Wan HJ, Lei F, Ding Y, Xing DM,
             TLR2 and TLR3: implication in Wallerian degeneration. Biochem   Du LJ. Comparative Study of the Effect of Baicalin and Its Natural
             Biophys Res Commun 2006;350:742-7.                  Analogs on Neurons with Oxygen and Glucose Deprivation Involving
          67.   Oliveira RB, Ochoa MT, Sieling PA, Rea TH, Rambukkana A,   Innate Immune Reaction of TLR2/TNF.  J Biomed Biotechnol
             Sarno EN, Modlin RL. Expression of Toll-like receptor 2 on human   2012;2012:267890.
             Schwann cells: a mechanism of nerve damage in leprosy. Infect   86.   Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002;30:S1-S11.
             Immun 2003;71:1427-33.                           87.   Jang H, Boltz D, Sturm-Ramirez K, Highly pathogenic H5N1
          68.   Lee H, Park C, Cho IH, Kim HY, Jo EK, Lee S, Kho HS, Choi SY,   influenza virus can enter the central nervous system and induce
             Oh SB, Park K, Kim JS, Lee SJ. Double-stranded RNA induces   neuroinflammation and neurodegeneration. Highly pathogenic
             iNOS gene expression in Schwann cells, sensory neuronal death,   H5N1 influenza virus can enter the central nervous system and
             and peripheral nerve demyelination. Glia 2007;55:712-22.  induce neuroinflammation and neurodegeneration. Proc Natl Acad
          69.   Cheng C, Qin Y, Shao X, Wang H, Gao Y, Cheng M, Shen A.   Sci U S A 2009;106:14063-8.


            36                                            Neuroimmunol Neuroinflammation |  Volume 3 | Issue 2 | February 15, 2016
   40   41   42   43   44   45   46   47   48   49   50